Updated OIG Bulletin on the Effect of Exclusion from Participation in Federal Health Care Programs

This post was written by Scot T. Hasselman and Susan A. Edwards.

The Office of Inspector General (OIG) of the Department of Health and Human Services (HHS) issued an updated “Special Advisory Bulletin on the Effect of Exclusion from Participation in Federal Health Care Programs ” (Updated Bulletin) on May 8, 2013, answering certain questions the OIG has received from providers and suppliers regarding exclusions and addressing other issues related to exclusions. The Updated Bulletin follows on a Special Advisory Bulletin regarding the same topic published by the OIG in September 1999. Since the OIG issued the 1999 Special Advisory Bulletin, Congress has enacted various statutory provisions that have strengthened the OIG’s authority to exclude individuals from federal health care programs and impose civil monetary penalties (CMPs) related to exclusion. The OIG states that in the development of the Updated Bulletin, it also relied on comments it received in response to a 2010 solicitation of comments on this topic.

The Updated Bulletin reflects a continuation of the OIG’s expansive view of the scope of the federal exclusion authorities, particularly relating to the prohibition against employing or contracting with excluded individuals and entities. The bulletin explains the statutory background of the exclusion and CMP authorities; describes the effect of exclusion; emphasizes the implications of violations of exclusion by an excluded individual and the implications for violating the prohibition against employment or contracting with an excluded individual for the furnishing of items or services paid for by a federal health care program; explains the scope of what conduct involving excluded individuals may lead to overpayment liability and CMPs; and provides guidance to providers and suppliers regarding how to screen for excluded individuals.

In the Updated Bulletin, the OIG clearly explains its broad interpretation of the prohibition on federal health care program payment for any items or services furnished by an excluded person or at the medical direction or on the prescription of an excluded person. The OIG points out that this prohibition applies to all methods of federal health care program payment. For example, as the OIG states in the Updated Bulletin, the prohibition would apply to an excluded nurse furnishing services to federal health care program beneficiaries in a hospital, even if the nurse’s services are not separately billed to a federal health care program. Further, the OIG makes clear that this prohibition would also apply to an individual who switches professions within the health care industry (e.g., if the OIG excluded an individual as a pharmacist, and that individual then trained to become a nurse, payment for any items or services furnished by the individual while performing the duties of a nurse would be prohibited). The OIG also explains that the prohibition would include items and services beyond direct patient care, such as the preparation of surgical trays, the review of treatment plans, and the order entry of prescriptions for pharmacy billing purposes. In addition, the Updated Bulletin explains that excluded persons may not furnish administrative or management services that are payable by federal health care programs. Moreover, an excluded individual serving in a leadership role, providing health information technology support, or facilitating human resources would violate the prohibition on payment.

In response to a question, the OIG’s Updated Bulletin addresses whether providers such as laboratories, pharmacies, and imaging centers are subject to liability if they furnish an item or service ordered by or prescribed by an excluded individual. The OIG asserts that such providers could be subject to liability and instructs that in order to avoid liability, such providers “should ensure, at the point of service, that the ordering or prescribing physician is not excluded.”

The OIG also explains that if an excluded individual owns more than a five percent ownership interest in a provider, that provider is potentially subject to permissive exclusion.

In a view that seems to exceed the scope of the applicable regulations, the Updated Bulletin explains that potential CMP liability for contracting with or employing an excluded individual could result even if the provider does not pay the excluded individual for his or her services. For example, the bulletin states that CMP liability could be triggered if a provider’s claim to a federal health care program includes any items or services furnished by an excluded health care professional who works at a hospital or nursing home as a volunteer. (Notably, the OIG broadly interpreted the prohibition for contracting with or employing an excluded individual in the 1999 Bulletin, but has not subjected its previous or current interpretation to notice and comment rulemaking.)

In a footnote, the OIG remarks that a hospital may reduce or eliminate its CMP liability if it can demonstrate that it reasonably relied on a staffing agency to conduct screenings of excluded individuals, and gives the example that such reliance may be demonstrated by contractual language showing that the staffing agency agreed to screen individuals and the hospital exercised due diligence to ensure the staffing agency met this obligation. The OIG later recommends that any provider that relies on contractors to perform exclusion screenings, such as a staffing agency, physician group, or third-party billing or coding company, validate that such contractor performs exclusion screenings by, for example, requesting and maintaining screening documentation from the contractor. Finally, the OIG emphasizes that regardless of whether a screening is performed, who performs a screening, and the relationship between the provider and the excluded individual (e.g., contractor, volunteer, employee), the provider would be liable for overpayments related to an excluded individual and may be subject to CMP liability.

Finally, the OIG provides guidance regarding screening individuals to determine whether a person is excluded from participation in the federal health care programs. In sum, the OIG recommends that providers check the List of Excluded Individuals and Entities (“LEIE”) prior to employing or contracting with persons and then “periodically” during the course of employment or a contract. While the OIG points out that there is no statutory or regulatory requirement to check the LEIE, it states that “screening employees and contractors each month best minimizes potential overpayment and CMP liability.” The Updated Bulletin also notes that CMS issued a State Medicaid Director Letter in 2009 that suggested states require providers to screen all employees and contractors monthly. The OIG also notes that it has received questions regarding whether the U.S. General Services Administration’s System for Award Management database or other sanctions databases should be used in addition to or instead of the LEIE to determine whether a provider has any sanctions against him or her. The OIG recommends that providers rely on the LEIE as the primary database for the purposes of exclusion screening. 

OIG Publishes Updated Provider Self-Disclosure Protocol

This post was written by Scot T. Hasselman and Susan A. Edwards.

The Office of Inspector General (OIG) of the Department of Health and Human Services (HHS) has issued a revised version of its Provider Self-Disclosure Protocol (Updated SDP), dated April 17, 2013, which established a process for health care providers to voluntarily identify, disclose, and resolve instances of potential fraud involving federal health care programs.  Specifically, this protocol is intended to address:  (1) conduct involving potential false billings; (2) conduct regarding excluded persons; (3) conduct involving potential violations of the Anti-Kickback Statute (AKS); and (4) conduct involving potential violations of the AKS and the Stark Law.

The Updated SDP provides guidance on how to investigate the conduct described above, quantify damages, and report such conduct to OIG to resolve the provider’s liability under OIG’s civil monetary penalty authorities.  The document supersedes the previous OIG Provider Self-Disclosure Protocol issued in 1998 and three previous “Open Letters to Health Care Providers.”  The OIG notes that over the past 15 years, it has resolved over 800 disclosures, resulting in recoveries of more than $280 million to federal health care programs.  The Updated SDP reflects the OIG’s experience with the protocol since 1988, along with feedback it received from the public in response to a June 18, 2012 comment solicitation.  

A summary of the Updated SDP, highlighting notable statements and requirements, is available in our Client Alert.

Proposed Rule Would Reward Medicare Fraud Tipsters up to $9.9 Million, Revise Medicare Provider Enrollment Regulations

This post was written by Scot T. Hasselman, Andrew C. Bernasconi, Susan A. Edwards and Debra A. McCurdy.

Yesterday the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that would dramatically increase the potential reward to an individual who provides a tip leading to the recovery of Medicare funds from a current maximum of $1,000 to a maximum of $9.9 million under the Medicare Incentive Reward Program.  Since 1998, an individual providing information regarding potential Medicare fraud and abuse to the Department of Health & Human Services’ Office of  Inspector General or the Medicare contractor with jurisdiction over the suspected fraudulent provider or supplier may be eligible to receive 10 percent of the Medicare funds ultimately collected from the tip, or $1,000, whichever is less.  Pursuant to the proposed rule CMS issued yesterday, an individual furnishing information that otherwise satisfies the requirements set forth in 42 C.F.R. § 420.405 would be eligible to receive 15 percent of a recovery up to $66 million.  Therefore, a tipster could receive up to a $9.9 million reward for any information provided regarding suspected Medicare fraud and abuse.

In the proposed Medicare Incentive Reward Program rule, CMS explains that it “tentatively project[s] a net increase in recoveries of $24.5 million per year as a result of the proposed changes.”  In addition, CMS notes that it is modeling the proposed Incentive Reward Program changes on a “highly successful” Internal Revenue Services (IRS) reward program that returned “far greater sums than the existing Medicare [Incentive Reward Program].”  Notably, since the implementation of the current Medicare Incentive Reward Program in July 1998, CMS has collected only $3.5 million; in contrast, between 2007 and 2012, the IRS has collected almost $1.6 billion through its reward program.  CMS states in the preamble that it proposes to clarify that it will not pay an award if the same or substantially similar information was the basis for a relators share in a qui tam lawsuit under the federal False Claims Act or a state False Claims Act, or is the basis for a pending state or federal False Claims Act suit.  However, the proposed regulatory language that would codify this change, found at proposed 42 C.F.R. § 420.405(b)(3), does not specify that this provision would apply to state False Claims Acts.

The proposed rule also would pay the reward amount only to the first individual who makes a report.  In addition, among other proposed changes to the regulations found at 42 C.F.R. § 420.405, CMS proposes to emphasize that it has exclusive discretion in determining the amount of a reward and whether the reward criteria are met.  The existing regulation provides for numerous other exceptions and conditions and generally excludes federal and state law enforcement officials, federal government employees, and federal contractors, from eligibility.

CMS also proposes several revisions to Medicare’s provider enrollment regulations, such as:

  • Allowing CMS to deny the enrollment of providers, suppliers, and owners affiliated with an entity that has unpaid Medicare debt;
  • Expanding the instances under which a felony conviction can serve as a basis for denial or revocation of a provider or supplier's enrollment;
  • Enabling CMS to revoke Medicare billing privileges if it determines that the provider or supplier has a pattern or practice of submitting claims for services that fail to meet Medicare requirements; and
  • Limiting the ability of ambulance suppliers to “backbill” for services performed prior to enrollment.

The proposed rule will be published in the April 29, 2013 edition of the Federal Register, and comments will be accepted for 60 days thereafter (June 28, 2013).

.

OIG Calls Medicare Supplier Surety Bonds "Underutilized" CMS Tool

The OIG has called on CMS to expand its use of surety bonds for Medicare DMEPOS suppliers, in a report entitled “Surety Bonds Remain an Underutilized Tool to Protect Medicare from Supplier Overpayments.”  Although CMS has required suppliers to obtain a minimum of $50,000 in surety bond coverage per location since 2009, the OIG found that CMS did not have accurate surety bond information for all Medicare suppliers as of 2011, and bonds in effect do not enable the agency to recoup all overpayments. As of August 2011, 1,429 suppliers owed $70 million to Medicare, but $20 million of this amount was owed by 312 suppliers without bonds. Out of the $50 million owed by bonded suppliers, the OIG estimates that $42 million will likely remain uncollected because the overpayment exceeds the $50,000 bond amount. The OIG recommends that CMS: improve oversight of supplier data to ensure accurate reporting; immediately begin recovering outstanding overpayments from suppliers’ surety bonds; consider using ACA authority to require increased surety bond amounts for suppliers receiving high levels of Medicare payments; and specify that collection of debts through surety bonds is based on dates of service. CMS concurred with the OIG recommendations, noting in its response to the report that as of July 2012, it has collected $263,000 in overpayments from sureties, and additional recoveries are expected. CMS also stated that it considering linking DMEPOS surety bond amounts to the volume of a supplier’s billing. CMS also is considering requiring home health agencies and certain other provider and supplier types to obtain and maintain surety bonds as a condition of enrollment. 

OIG Releases FY 2012 Medicaid Integrity Report

The OIG has released its Medicaid Integrity Program Report for FY 2012, which provides information on the OIG's Medicaid program integrity funding, summarizes significant OIG Medicaid-related reviews and investigations, and highlights Medicaid-related projects included in the OIG’s Work Plan for FY 2013.

OIG Identifies Gaps in Private Insurer Reporting to HealthCare.Gov Plan Finder Portal

All private health insurers in the individual and small group markets must submit data to the HealthCare.gov Plan Finder, an online portal created to help consumers compare health insurance coverage options. According to a recent OIG report, "Oversight of Private Health Insurance Submissions to the HealthCare.gov Plan Finder," while most private insurers reported data to the Plan Finder, the OIG found inconsistent data displayed for a sample of products and plans. The OIG also identified gaps in CMS’s oversight of compliance with reporting requirements, such as a lack of targeted follow-up with insurers that did not report detailed pricing and benefit information. The OIG recommends that CMS: implement procedures to identify and pursue insurers that do not submit required data; require each private insurer’s Chief Executive Officer or Chief Financial Officer to certify to the completeness of data submitted to the Plan Finder; and take certain other steps to ensure the accuracy of Plan Finder data and the availability of plans identified on Plan Finder.. CMS generally concurred with the recommendations. 

CMS, OIG Propose Extension of Electronic Health Record Donation Protections

This post was written by Jennifer Pike.

CMS and the OIG have proposed new rules to extend existing protections that allow hospitals to donate electronic health record (EHR) technology to physicians who refer patients to their facilities. By way of background, in 2006, CMS established an exception to the Stark self-referral law to allow hospitals to donate EHR technology to physicians under certain circumstances. Likewise, in 2006, the OIG established a safe-harbor to protect such EHR donations from enforcement under the federal anti-kickback statute. While both protections are set to expire on December 31, 2013, the proposed rules would extend the provisions until the end of 2016 as a means to facilitate the adoption of EHR technology. The proposed rules also would (1) remove the requirement from the original rule that donated EHR technology contain electronic prescribing capability, and (2) update the provision under which EHR technology is deemed interoperable, which would expand the types of EHR systems that qualify for the protections. Comments on both proposed rules will be accepted until June 10, 2013.

OIG Updates Guidelines for Evaluating State False Claims Acts

The OIG has updated its 2006 guidelines on how it determines whether a state false claims act law meets certain federal standards. By way of background, to encourage improved state efforts to fight Medicaid fraud, the Deficit Reduction Act (DRA) enables states that adopt state false claims acts to retain a greater portion of Medicaid overpayments. Specifically, the DRA decreases the federal government’s share of any Medicaid overpayment by 10 percentage points for any state that enacts a false claim act that meets standards established by HHS, effective January 1, 2007. To qualify, the state law must: (1) establish liability to the state for false or fraudulent claims described in the federal False Claims Act (FCA), with respect to Medicaid expenditures; (2) contain provisions that are at least as effective in rewarding and facilitating qui tam actions as those in the federal FCA; (3) contain a requirement for filing an action under seal for 60 days with review by the state Attorney General; and (4) contain a civil penalty that is not less than the amount authorized by the federal FCA. In August 2006, the OIG released guidelines on how it will determine whether a state law meets the DRA's requirements.  The new guidelines to reflect subsequent amendments to the FCA that modified the bases for FCA liability, expanded the rights of qui tam relators, and added an express requirement that civil penalties include adjustments under the Federal Civil Penalties Inflation Adjustment Act of 1990.  The guidelines also provide more specificity regarding the OIG’s standards based on the OIG’s experience in reviewing state laws to date. Notably, the new guidelines provide more prescriptive requirements for state laws pertaining to “Rewarding and Facilitating Qui Tam Actions,” with the OIG now expecting state laws to include 14 rather than 8 elements in this area.  The new guidelines are effective March 15, 2013.

OIG Special Fraud Alert Deems Physician-Owned Distributors (PODs) As "Inherently Suspect" Under Anti-Kickback Statute

On March 26, 2013, the HHS Office of Inspector General (OIG) released a Special Fraud Alert highlighting the risks associated with PODs -- physician-owned entities that sell (or arrange for the sale of) implantable medical devices ordered by their physician-owners for use in procedures the physician-owners perform on their own patients at hospitals or ambulatory surgical centers. Building on previous OIG and Congressional scrutiny of PODs, the Special Fraud Alert details specific attributes and practices of PODs that the OIG believes “produce substantial fraud and abuse risk and pose dangers to patient safety.”  A Reed Smith analysis of the Alert is available on our Life Sciences Legal Update blog.

OIG Examines SNF Care Planning/Discharge Planning

The OIG has issued a report, “Skilled Nursing Facilities Often Fail to Meet Care Planning and Discharge Planning Requirements,” assessing SNF compliance with federal requirements to develop a care plan for each Medicare beneficiary, provide services in accordance with the individual’s care plan, and establish a discharge plan for each beneficiary. Based on an extremely small sample of only 190 SNF stays in 2009 – which OIG projects to more than 1.1 million stays – the OIG estimates that 37% of SNFs did not develop care plans that met federal requirements or did not provide services in accordance with care plans. In addition, the OIG estimates that SNFs did not meet discharge planning requirements in 31% of stays. The report also reviews examples of what it considers poor quality of care in the SNF setting, including a few cases involving wound care, medication management, and therapy. In response to these findings, the OIG recommends that CMS, among other things: strengthen care planning and discharge planning regulations; provide more detailed guidance to SNFs; improve surveyor efforts to identify and hold accountable SNFs that do not meet care and discharge planning requirements; and link payments to meeting quality-of-care requirements (such as by incorporating quality measures for care planning and discharge planning in its SNF Value-Based Purchasing program). CMS concurred with the OIG’s recommendations and discussed the status of its efforts in this area. Related OIG information is posted here

OIG Finds Some LTCHs Have Not Reported Co-Located Status

The OIG has examined the extent to which long-term care hospitals (LTCHs) that are co-located with another hospital-level provider or a skilled nursing facility disclose their co-location status to their Medicare contractor. Because co-located status can impact Medicare payments, co-located LTCHs and satellite facilities must notify their MAC and CMS Regional Office about the provider(s) with which they are co-located within 60 days of their first cost-reporting period. Based on a review of 141 LTCHs that the OIG had previously determined were co-located, the OIG found that only 44 had notified their Medicare contractor of their co-located status. While the report, Co-Located Long-Term Care Hospitals Remain Unidentified, Resulting in Potential Overpayments, does not contain recommendations, the OIG observes that “inaccurate data on LTCHs’ co located status could result in overpayments.” In addition, the OIG noted that it continues to study Medicare payments to LTCHs for interrupted stays. The OIG intends to provide additional information on interrupted stays and make recommendations to CMS in a final report.

CMS Plans to Include DME Infusion Drugs in Competitive Bidding in Response to OIG Findings

A new OIG report, “Part B Payments for Drugs Infused through Durable Medical Equipment,” calls for changes in the Medicare reimbursement methodology for Part B infusion drugs administered in conjunction with DME in light of potentially inaccurate pricing. By way of background, DME infusion drugs are reimbursed at 95% of the drug’s average wholesale price (AWP) in effect on October 1, 2003, compared to 106% of the average sales price (ASP) for most Part B drugs. Based on a comparison of actual Medicare reimbursement and the amount that would have been paid under the ASP methodology for each DME infusion drug from 2005 to 2011, the OIG found that payment exceeded ASPs by 54%-122% annually. On the other hand, reimbursement for up to one-third of DME infusion drugs were below the ASP, indicating that in some cases Medicare may underpay for these drugs. On the whole, the OIG estimates that Medicare spending on DME infusion drugs would have been cut by 44% ($334 million) between 2005 and 2011 if payment had been based on ASP. The OIG recommends that CMS either (1) seek legislation requiring DME infusion drug payment to be based on ASP, or (2) include DME infusion drugs in the next round of the DMEPOS competitive bidding program. CMS was noncommittal on legislative changes, but said it would include ME infusion drugs in the next round of competitive bidding (CMS has not yet provided other details on future expansion of competitive bidding). 

OIG Calls for Stronger Conflict-of-Interest Oversight for Medicare Part D P&T Committees

A recent OIG report, “Gaps in Oversight of Conflicts of Interest in Medicare Prescription Drug Decisions,” examines how Medicare Part D drug plan pharmacy and therapeutics (P&T) committees ensure that formulary decisions are not biased by conflicts of interest. Based on a survey of P&T committees and a review of their written policies, along with interviews with CMS, the OIG concluded that “both sponsors and CMS conduct limited oversight of P&T committee conflicts of interest, compromising their ability to ensure that financial interests do not influence formulary decisions.” For instance, most sponsors’ P&T committees have limited definitions of conflicts of interest (more than half did not define any financial interests with sponsors or pharmaceutical manufacturers as conflicts of interest), which the OIG believes could prevent them from identifying conflicts. Moreover, many sponsors’ P&T committees rely on their members to determine and manage their own conflicts. CMS also does not adequately oversee compliance with the regulatory requirement that at least two members on each P&T committee be independent and free of conflict relative to the plan sponsor and pharmaceutical manufacturers, according to the OIG. The OIG makes a series of recommendations intended to strengthen conflict-of-interest policies, including recommending that CMS: require P&T committee members to be free of conflict with any pharmacy benefit manager that manages a sponsor’s prescription drug benefit; direct sponsors to ensure that objective processes are used to determine and manage conflicts; and oversee sponsors’ compliance with the requirement that at least two committee members be independent and free of conflict.

OIG Continues to Call on CMS to Implement Medicare Part B Drug Pricing Reforms

For the 29th time, the OIG has issued a report comparing Medicare Part B drug average sales prices (ASP) and average manufacturer prices (AMP), this report covering all of 2011. The OIG again concludes that the Medicare would realize savings if it exercised its authority to lower reimbursement for Part B drugs when the drugs ASP exceeds its drug's AMP or widely available market price (WAMP) by a threshold, currently set at 5%. Although CMS has finalized regulations specifying the circumstances under which AMP-based price substitutions could occur, no such substitutions have been made to date. The OIG estimates that if CMS’s price substitution policy had been in effect, Medicare would have saved about $7 million in 2011; this amount would have been doubled if the substitution policy were applied to all codes that exceeded the 5% threshold in one or more quarters of 2011 when complete AMP data were used. CMS concurred with an OIG recommendation to finalize its substitution policy, but it did not support OIG recommendations to expand the substitution policy to include all codes with complete AMP data and certain codes with partial AMP data. CMS also rejected an OIG recommendation to seek a legislative change to require manufacturers of Part B-covered drugs to submit both ASPs and AMPs.

FY 2012 Health Care Fraud and Abuse Control Program Report

On February 11, 2013, the Obama Administration announced that anti-fraud efforts under the Health Care Fraud and Abuse Control Program (HCFAC) recovered a record-breaking amount of $4.2 billion in FY 2012. More specifically, in 2012 the Justice Department opened 1,131 new criminal health care fraud investigations involving 2,148 potential defendants, and a total of 826 defendants were convicted of health care fraud-related crimes. The DOJ also opened 885 new civil investigations, obtained settlements and judgments of more than $3 billion in FY 2012 under the False Claims Act, and collected nearly $1.5 billion in fines and forfeitures under the Federal Food, Drug and Cosmetic Act. Obama Administration officials emphasized that efforts to reduce fraud will continue to expand with new tools and resources provided by the ACA, including enhanced screening and enrollment requirements (which have eliminated nearly 150,000 ineligible providers from the Medicare rolls), increased data sharing across the government, expanded overpayment recovery efforts, and greater oversight regarding private insurance.

OIG Continues to Fault Efforts to Prevent Medicare Fraud in Community Mental Health Centers

The OIG has examined CMS efforts to prevent fraud and abuse at community mental health centers (CMHCs), which provide partial hospitalization program services (structured outpatient mental health treatment programs) to qualifying Medicare beneficiaries. The OIG has previously reported that CMHCs may be particularly vulnerable to fraud, waste, and abuse involving PHP services, with approximately half of CMHCs exhibiting questionable billing in 2010. The OIG’s new report is entitled, Vulnerabilities in CMS's and Contractors' Activities to Detect and Deter Fraud in Community Mental Health Centers. The OIG found that most Medicare Administrative Contractor (MAC) and Zone Program Integrity Contractor (ZPIC) activities to detect and deter CMHC fraud in 2010 were actually performed in conjunction with the CMS-led South Florida High-Risk Provider Enrollment Project; other MACs and ZPICs performed minimal activities to detect and deter fraudulent CMHC billing despite having jurisdiction over fraud-prone areas. The OIG also found that Medicare paid noncompliant CMHCs after their revocations were effective and while their revocations were being approved. To address program vulnerabilities, the OIG recommends that CMS: implement additional CMHC fraud mitigation activities in fraud-prone areas; improve tracking of revocations; coordinate activities to deter CMHC fraud in Florida; and follow up on payments made to CMHCs after revocations.

OIG Calls for Improvements to Medicare Parts C & D Benefit Integrity Activities

The OIG recently identified barriers to the effectiveness of the Medicare Drug Integrity Contractor (MEDIC) in performing Medicare Parts C and D benefit integrity activities between April 2010 and March 2011. For instance, the MEDIC reported that it does not have access to centralized Part C data, it lacks access to certain prescription drug event data, and there is no mechanism to recover payments from Part C or Part D plan sponsors when law enforcement agencies do not accept these cases for further action. Moreover, while the MEDIC has benefit integrity responsibility for both Medicare Parts C and D, the OIG determined that Part C investigations and case referrals represented a small percentage of its activities (only 8% of investigations and referrals involved Part C only; the majority were Part D only). The OIG makes a series of recommendations to, among other things: improve the data available to the MEDIC (including information from pharmacies, physicians, and pharmacy benefit managers); expand the ability of the MEDIC to recover payments from Part C and Part D plan sponsors; and require Part C and Part D plan sponsors to refer potential fraud and abuse incidents to the MEDIC. For details, see the full report, MEDIC Benefit Integrity Activities in Medicare Parts C and D.

OIG Assesses State Medicaid Third-Party Liability Collection

The OIG has reviewed the extent to which states have improved collection of third-party liability (TPL) payments in situations where Medicaid beneficiaries have additional sources of health insurance that are responsible for payment. According to the OIG report, Medicaid Third-Party Liability Savings Increased, But Challenges Remain, states reported that TPL savings increased from almost $34 billion in 2001 to more than $72 billion in 2011. Nevertheless, states generally were not able to recover all of third-party obligations, leaving an estimated $4 billion at risk of not being recovered. The OIG recommends that CMS: work with states to address longstanding challenges related to identification of insurance coverage and recovery of payments; address states' challenges with 1-year timely filing limits for Medicare and TRICARE; and strengthen enforcement mechanisms designed to deal with uncooperative third parties. CMS concurred with the recommendations. 
 

Improper Medicare Payments for Unlawfully Present, Incarcerated Beneficiaries

The OIG has discovered that Medicare has paid millions of dollars in benefits for aliens who are not lawfully present in the country and for incarcerated beneficiaries, contrary to program rules. Specifically Medicare made $91.6 million in payments to health care providers for services to approximately 2,600 unlawfully present beneficiaries during calendar years 2009 through 2011 because CMS did not always receive the unlawful presence information promptly. Likewise, because CMS did not always receive incarceration information promptly, Medicare paid $33.6 million for services to approximately 11,600 incarcerated beneficiaries during 2009 through 2011, even though prisons generally are responsible for paying for care (Medicare will make payments for incarcerated patients if state or local law requires the individuals to repay the cost of the services, but providers must submit such claims with an "exception code"). The OIG recommends that CMS ensure that its contractors recoup any improper payments, implement various policies and procedures to detect and recoup future improper payments, and standardize contractor processing of exception codes for incarcerated beneficiaries. Additional details can be found in the complete reports, Medicare Improperly Paid Providers Millions of Dollars for Unlawfully Present Beneficiaries Who Received Services During 2009 Through 2011 and Medicare Improperly Paid Providers Millions of Dollars for Incarcerated Beneficiaries Who Received Services During 2009 Through 2011.

OIG Calls for Cuts in Medicare Rates for Back Orthoses

The OIG is calling on CMS to lower Medicare payment for certain back orthosis products, either by subjecting these products to the Medicare durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) competitive bidding program or by making an inherent reasonableness adjustment. This recommendation stems from the OIG’s findings that Medicare payment amounts far exceeded supplier acquisition costs for lumbar-sacral orthoses billed under L0631. Specifically, between July 2010 and June 2011, the average Medicare-allowed amount for L0631 was $919, compared to the average supplier acquisition cost of $191, resulting in Medicare paying an estimated $37 million more than supplier costs. Moreover, while the code descriptor for L0631 references fitting and adjustment services, the OIG found that for 33% of claims the supplier did not report providing such services, and only 7% of suppliers reported providing any additional services other than general instructions. CMS agreed that Medicare payments for back orthoses billed under HCPCS code L0631 “should be adjusted to more closely reflect the supplier’s acquisition costs for the device and the level of service provided when furnishing the device.” CMS indicated that it would be pursing competitive bidding rather than an inherent reasonableness adjustment, noting that it is working to finalize its classification of HCPCS codes that may be considered to be “off-the-shelf” orthotics and subject to DMEPOS competitive bidding (the preliminary classification list included HCPCS code L0631). 

Older Entries

January 14, 2013 — OIG Finds DMEPOS Competitive Bidding Not Spurring Suppliers to Solicit Specific Brands/Modes of Delivery

January 14, 2013 — OIG Assesses Medicare Oversight of Home Health Agencies

January 14, 2013 — OIG Invites Proposals for Anti-Kickback Safe Harbors, Fraud-Alerts

January 11, 2013 — OIG Issues Medicare Part B Drug Pricing Report, Calls Out CMS Inaction on Reforms

December 19, 2012 — OIG Highlights Vulnerabilities in CMS Oversight of the Medicare EHR Incentive Program

December 17, 2012 — OIG Releases 2012 Compendium of Unimplemented Recommendations

December 17, 2012 — OIG Report on Medicare Part B Drug Pricing Data

November 29, 2012 — OIG Outlines Top HHS Management Challenges

November 29, 2012 — OIG Recommends Resurrection of Least Costly Alternative (LCA) Drug Policy

November 29, 2012 — OIG Calls for Improvements in Medicare Appeals Process

November 29, 2012 — OIG Finds Overwhelming Hospital Compliance with Present on Admission (POA) Indicator Reporting

November 28, 2012 — OIG Reports Almost $7 Billion in Audit/Investigation Recoveries for FY 2012

November 14, 2012 — OIG Reviews Impact of DMEPOS Bidding Program on Billing for Diabetes Test Strips (DTS)

November 14, 2012 — OIG Examines Inappropriate Medicare Payments to SNFs

October 30, 2012 — OIG Calls on CMS to Implement Medicaid Drug AMP-Based FUL Payments

October 16, 2012 — OIG Issues FY 2013 Work Plan

October 16, 2012 — OIG Report on Criminal Convictions of Nurse Aides with Substantiated Findings of Abuse, Neglect, & Misappropriation

October 15, 2012 — OIG Compliance Roundtable: "The Next Generation of Corporate Integrity Agreements"

October 15, 2012 — OIG Assesses Inappropriate Medicare Part D Payments for Schedule II Drugs Billed as Refills

October 15, 2012 — OIG Faults CMS Failure to Implement HHA Surety Bond Rule

October 15, 2012 — OIG Calls on CMS to Implement Safeguards for the Medicare Prosthetics/Orthotics Benefit

October 15, 2012 — OIG Examines Employment of Excluded Individuals by Medicaid Managed Care Entity Providers

October 15, 2012 — OIG Recommends Improvements to CMS Response to Health Information Breaches

October 11, 2012 — OIG to Host "Outlook 2013" Webcast (Oct. 24)

September 27, 2012 — State Collection of Medicaid Rebates for Drugs Paid Through Medicaid MCOs

September 27, 2012 — OIG Finds Lax CMS Healthcare Integrity and Protection Data Bank Reporting

September 5, 2012 — OIG Identifies Questionable Community Mental Health Center Billing

September 5, 2012 — OIG Offers Web Course on Safeguarding Medical Identity.

August 17, 2012 — OIG Reports on Questionable Medicare HHA Billing

July 31, 2012 — OIG Highlights Adverse Events in Hospitals

July 31, 2012 — OIG Examines CMS Reconciliation of Medicare Hospital Outlier Payments

July 19, 2012 — OIG Highlights Potential ZPIC Conflicts of Interest

June 27, 2012 — OIG, GAO Review Medicaid HCBS Programs

June 27, 2012 — OIG Faults DME MAC Review of High Utilization Claims for Diabetic Testing Supplies

June 27, 2012 — OIG Assesses Extent of Physician EHR Use

June 18, 2012 — OIG Considering Revisions to Provider Self-Disclosure Protocol

June 13, 2012 — OIG Concludes Part D Plans Include Drugs Used by Dual Eligibles

May 31, 2012 — OIG Releases Spring 2012 Semiannual Report

May 31, 2012 — OIG Reports on Obstacles to Collecting Medicare Overpayments

May 14, 2012 — Three OIG Reports Review Medicare E/M Services

May 14, 2012 — Medicare Payment for Vision-Loss Drugs Reviewed by OIG

April 23, 2012 — OIG Finds Limited Benefit of Medicare-Medicaid Data Match Program

April 23, 2012 — OIG Examines Nursing Home Emergency Preparedness

April 23, 2012 — OIG Issues FY 2011 Medicaid Integrity Program Report

April 23, 2012 — OIG Reviews Questionable Medicare Billing for IDTF Services

April 2, 2012 — OIG Examines Medicaid Payments for Therapy Services

April 2, 2012 — OIG Release Report from Pharmaceutical Compliance Roundtable

March 14, 2012 — OIG Report on Excluded Providers in Medicaid Managed Care Plans

March 14, 2012 — OIG Reports Examine Home Health Agency (HHA) Issues

March 14, 2012 — Quality Assurance, Care at HRSA-Funded Health Centers Reviewed

March 14, 2012 — OIG Issues Fraud Alert for People with Diabetes

March 14, 2012 — OIG Compliance Toolkit for Health Care Boards

February 28, 2012 — OIG Examines MA Organizations' Identification of Potential Fraud & Abuse

February 28, 2012 — FY 2011 Health Care Fraud and Abuse Control Program Report

February 13, 2012 — OIG Cautions Physicians on Reassigning Medicare Billing Rights

January 5, 2012 — Annual OIG Solicitation of New Safe Harbors, Special Fraud Alerts

January 4, 2012 — OIG Report on Portable X-Ray Supplier Billing Patterns

December 13, 2011 — OIG Posts Compliance Training Videos/Podcasts

December 1, 2011 — Reed Smith Analysis and Overview of the Medicare Shared Savings Program for Accountable Care Organizations

November 30, 2011 — OIG Issues Semiannual Report for Second Half of FY 2011

November 29, 2011 — OIG Examines How Part D Limits Drugs to Medically-Accepted Indications

November 29, 2011 — OIG Report Compares ASPs, AMPs for 2010

November 14, 2011 — OIG Highlights Medicaid Rebate Program, Indian Health Services (IHS) Issues

November 13, 2011 — OIG Examines Medicare's Response to Hospital Adverse Events

October 28, 2011 — OIG Reviews Medicaid Drug Expenditure Controls

October 28, 2011 — OIG Report Examines Drug Costs to Medicaid Pharmacies

October 20, 2011 — CMS Releases Final Medicare Shared Savings Program/ACO Rule

October 14, 2011 — OIG Proposes Revisions to Performance Standards for State Medicaid Fraud Control Units, Posts Interactive MFCU Statistical Map

October 14, 2011 — OIG FY 2012 Work Plan Released

September 27, 2011 — OIG Reviews Place-of-Service Coding for Physician Services

September 27, 2011 — OIG "Spotlight" on IDTFs

August 16, 2011 — OIG Follow-Up Report on Medicaid Hospital Outlier Payments

August 9, 2011 — CMS "Provider Compliance Group Outreach Calls" to Focus on Medicare Vulnerabilities (Aug. 23-25, 2011)

July 18, 2011 — OIG Reports on Nursing Home Reimbursement

May 13, 2011 — OIG Report on Medicare Part B Third Quarter Drug Payments

May 13, 2011 — GAO, OIG Reports on Nursing Home Oversight and Care

March 29, 2011 — OIG Proposes to Allow Medicaid Fraud "Data Mining"

March 29, 2011 — Compendium of Unimplemented OIG Recommendations

March 29, 2011 — GAO and OIG Examine Medicare Part D Issues

March 19, 2011 — CMS Calls: Provider Compliance Group National Outreach/OIG Reports (March 22-24)

March 7, 2011 — OIG Identifies Top HHS Management Challenges, Including ACA Implementation

March 7, 2011 — OIG Report on Nursing Home Workers with Criminal Convictions

March 7, 2011 — OIG Faults Part D Rebate Reporting

March 7, 2011 — OIG Report on High-Utilization Diabetes Supply Claims

February 21, 2011 — Interesting health care fraud prosecution data contained in letter to Senator Charles Grassley

February 18, 2011 — Reprocessing Medicare Claims Affected by ACA/2010 Medicare Physician Fee Schedule Changes

February 1, 2011 — OIG to Offer Local Health Care Law Compliance Training Sessions

January 28, 2011 — HHS Issues FY 2010 Health Care Fraud and Abuse Control Program Report

January 13, 2011 — OIG Reports on Institutional Conflicts of Interest at NIH Grantees

January 13, 2011 — OIG Report on Medicare Payments for Newly Available Generic Drugs

December 29, 2010 — Annual OIG Solicitation of Anti-Kickback Safe Harbors, Special Fraud Alerts

December 21, 2010 — Pharmaceutical Executives and In-House Counsel Beware: U.S. District Court Affirms Exclusion of Former Purdue Executives Under "Responsible Corporate Officer" Doctrine

December 15, 2010 — OIG Report on Medicaid Personal Care Services

December 15, 2010 — OIG Report on Mail Order Diabetic Testing Strips

November 29, 2010 — OIG Seeks Comments on Updating OIG Exclusion Bulletin

November 29, 2010 — OIG Report on FDA's Approval Status of Drugs Paid for by Medicaid

November 29, 2010 — Adverse Events in Hospitals Involving Medicare Beneficiaries

November 29, 2010 — Medicare Part D Pharmacy Discounts

November 15, 2010 — OIG Anti-Fraud "Roadmap" for New Physicians

November 15, 2010 — OIG Report on Suspension of Medicare Payments